The revenue forecast provided by PTC Therapeutics covers a range that includes and exceeds the current analyst estimate. This could be interpreted as a positive signal by investors, suggesting that the company has the potential to outperform expectations. The high end of the forecast is significantly above the estimate, which may lead to a positive short-term impact on the stock price if investors focus on the growth potential.